Package 16729-434-45

Brand: daptomycin

Generic: daptomycin
NDC Package

Package Facts

Identity

Package NDC 16729-434-45
Digits Only 1672943445
Product NDC 16729-434
Description

10 VIAL in 1 CARTON (16729-434-45) / 7 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2020-02-27
Brand daptomycin
Generic daptomycin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "40bc42f7-4d83-0e17-e063-6394a90ad5d2", "openfda": {"nui": ["N0000175509", "M0519359"], "upc": ["0316729434058", "0316729434454"], "unii": ["NWQ5N31VKK"], "rxcui": ["1996246"], "spl_set_id": ["f69e9306-ffac-41c9-b277-a6d784f2e341"], "pharm_class_cs": ["Lipopeptides [CS]"], "pharm_class_epc": ["Lipopeptide Antibacterial [EPC]"], "manufacturer_name": ["Accord Healthcare, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (16729-434-05)  / 7 mL in 1 VIAL", "package_ndc": "16729-434-05", "marketing_start_date": "20190716"}, {"sample": false, "description": "10 VIAL in 1 CARTON (16729-434-45)  / 7 mL in 1 VIAL", "package_ndc": "16729-434-45", "marketing_start_date": "20200227"}], "brand_name": "Daptomycin", "product_id": "16729-434_40bc42f7-4d83-0e17-e063-6394a90ad5d2", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Lipopeptide Antibacterial [EPC]", "Lipopeptides [CS]"], "product_ndc": "16729-434", "generic_name": "Daptomycin", "labeler_name": "Accord Healthcare, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daptomycin", "active_ingredients": [{"name": "DAPTOMYCIN", "strength": "350 mg/7mL"}], "application_number": "ANDA212667", "marketing_category": "ANDA", "marketing_start_date": "20190716", "listing_expiration_date": "20261231"}